Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs

Cardiovascular diseases (CVD) and cancer are still the leading causes of death. There are many common etiologic factors, especially smoking and obesity. Therefore, it is not uncommon for CVD and cancer to coexist. Drug-drug interactions (DDIs) inevitably occur in this group of patients, where polyph...

Full description

Saved in:
Bibliographic Details
Published in:Critical reviews in oncology/hematology 2020-01, Vol.145, p.102822-102822, Article 102822
Main Authors: Akbulut, Muge, Urun, Yuksel
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Agents - adverse effects
Antineoplastic Agents - pharmacology
Cancer
Cardiology
Cardiovascular Agents - adverse effects
Cardiovascular Agents - pharmacology
Cardiovascular disease
Cardiovascular Diseases - drug therapy
Drug Interactions
Drug-drug interaction
Humans
Neoplasms - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular diseases (CVD) and cancer are still the leading causes of death. There are many common etiologic factors, especially smoking and obesity. Therefore, it is not uncommon for CVD and cancer to coexist. Drug-drug interactions (DDIs) inevitably occur in this group of patients, where polypharmacy is increasing due to older age and multiple comorbidities. However, multidisciplinary studies, especially close collaboration of medical oncologists and cardiologists, who deals with the diagnosis and treatment of these diseases, awareness and preventive approaches to DDIs may reduce serious morbidity and mortality. In this review, information about the common treatments used in cardiology and oncology and possible DDIs are discussed.
ISSN:1040-8428
1879-0461
DOI:10.1016/j.critrevonc.2019.102822